Quetiron XR Acino 50mg 60 tablets — Made in Greece — Free Delivery

Product description

Quetiron® XR Asino tablets are prescribed for the following indications:

• Schizophrenia, including prevention of relapse in patients with stable schizophrenia who received maintenance therapy with Quetiron® XR Asino.
• Bipolar disorder in particular.
• As an adjunctive therapy for severe depressive episodes in patients with severe depressive disorder (TIR), in which a suboptimal response to antidepressant monotherapy is recorded. Before starting therapy, the doctor must carefully study the safety profile of Quetiron® XR Asino.

Compound

active substance: quetiapine;

1 tablet contains 57.56 mg or 172.68 mg 345.36 mg quetiapine fumarate, which is equivalent to 50 mg or 150 mg or 300 mg quetiapine;

excipients: methacrylate copolymer (type A), lactose (SD 250), crystalline maltose (Advantose 100), talc, vegetable magnesium stearate;

shell composition: methacrylate copolymer (type A), triethyl citrate (Citrofol).

Contraindications

Hypersensitivity to the active substance or to any component of the preparation.

Concomitant use of cytochrome P450 3A4 inhibitors such as HIV protease inhibitors, azole antifungals, erythromycin, clarithromycin and nefazodone is contraindicated.

Mode of application

There are different dosing regimens for each indication. It should be ensured that the patient is prescribed dosages that are appropriate for his condition.

Quetiapine should be used once a day on an empty stomach. The tablets should be swallowed whole without breaking, chewing or crushing them.

Application features

Pregnant

During pregnancy, quetiapine can be prescribed only if the expected benefit outweighs the potential risk.

Children

Quetiapine is not recommended for use in children due to the lack of data to support its use in this age group.

Drivers

Given the main effect of quetiapine on the central nervous system, the preparation may interfere with activities requiring attention. Therefore, patients are not recommended to drive a car and use machinery until the individual sensitivity to such effects has been clarified.

Overdose

In general, the signs and symptoms of overdose were the result of an increase in known pharmacological effects, such as drowsiness and sedation, tachycardia, arterial hypotension and anticholinergic effects. Overdose can lead to prolongation of the QT interval, convulsions, status epilepticus, rhabdomyolysis, respiratory depression, urinary retention, disorientation, delirium and / or agitation, coma, and death. Patients with existing severe cardiovascular disease may have an increased risk of overdose effects (see section "Peculiarities of use").

Adverse Reactions

When taking quetiapine, the following adverse reactions were more often reported: drowsiness, dizziness, headache, dry mouth, mild asthenia, constipation, tachycardia, orthostatic hypotension and dyspepsia.

Interaction

Caution should be exercised with the simultaneous use of quetiapine with preparations that disrupt the electrolyte balance or prolong the QT interval.

In patients receiving quetiapine, there were cases of false positive results of an enzyme immunoassay for the presence of methadone and tricyclic antidepressants. It is recommended that questionable immunoassay screening results be checked using an appropriate chromatographic method.

Storage conditions

Store in original packaging, out of reach of children. Does not require special storage conditions.

Shelf life. 3 years.